Zomig - Treatment of Acute Migraine Headache in Adolescents
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate if Zomig® Nasal Spray will help children (age
12-17 years) with migraine headaches feel better. This will be done by comparing 3 different
doses of Zomig Nasal Spray with placebo nasal spray (inactive treatment).